Skip to main content

Table 2 Baseline characteristics of the subjects according to follow-up outcomes

From: Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study

Variables Subjects developed HTN (n = 2047) Subjects did not develop HTN (n = 2639) p
TyG 8.55 (8.20–8.92) 8.23 (7.92–8.59) < 0.001
Gender (male/female, n) 1541/506 1636/1003 < 0.001
Age (years) 44.0 (36.0–54.0) 38.0 (33.0–46.0) < 0.001
BMI (kg/m2) 23.6 (21.8–25.4) 21.7 (19.8–23.6) < 0.001
SBP (mmHg) 124.0 (117.0–131.0) 112.0 (105.0–120.0) < 0.001
DBP (mmHg) 80.0 (75.0–84.0) 71.0 (67.0–76.0) < 0.001
WC (cm) 81.0 (75.0–87.0) 75.0 (69.0–81.0) < 0.001
BUN (μmol/L) 5.09 (4.29–5.96) 4.86 (4.15–5.66) < 0.001
Cr (μmol/L) 74.0 (64.0–83.0) 71.0 (60.0–80.0) < 0.001
FPG (mmol/L) 4.53 (4.21–4.89) 4.37 (4.09–4.66) < 0.001
UA (μmol/L) 342.0 (284.0–395.0) 306.0 (250.0–364.0) < 0.001
AST (U/L) 20.0 (17.0–25.0) 19.0 (16.0–23.0) < 0.001
ALT (U/L) 25.0 (17.0–37.0) 20.0 (15.0–30.0) < 0.001
γ-GGT (U/L) 21.0 (15.0–34.0) 16.0 (11.0–24.0) < 0.001
TC (mmol/L) 4.83 (4.28–5.50) 4.56 (3.99–5.14) < 0.001
TG (mmol/L) 1.38 (1.01–2.02) 1.07 (0.80–1.51) < 0.001
HDL-C (mmol/L) 1.26 (1.07–1.52) 1.27 (1.08–1.58) 0.020
LDL-C (mmol/L) 2.73 (2.24–3.29) 2.51 (2.04–3.03) < 0.001
Apo-A1 (g/L) 1.29 (1.13–1.50) 1.30 (1.13–1.48) 0.815
Apo-B (g/L) 0.97 (0.81–1.14) 0.85 (0.71–1.01) < 0.001
eGFR (mL/(min·1.73 m2)) 108.0 (95.0–122.0) 111.6 (100.2–126.2) < 0.001